| Literature DB >> 28626267 |
Lin Qiu1, Kai Tian1, Jian Pan1, Lin Jiang1, Hu Yang2, Xiangcheng Zhu1,3,2, Ben Shen4,5,6, Yanwen Duan1,3,2,7, Yong Huang1,3,7.
Abstract
Platensimycin (PTM), produced by several strains of Streptomyces platensis, is a promising drug lead for infectious diseases and diabetes. The recent pilot-scale production of PTM from S. platensis SB12026 has set the stage for the facile semi-synthesis of a focused library of PTM analogues. In this study, gram-quantity of platensic acid (PTMA) was prepared by the sulfuric acid-catalyzed ethanolysis of PTM, followed by a mild hydrolysis in aqueous lithium hydroxide. Three PTMA esters were also obtained in near quantitative yields in a single step, suggesting a facile route to make PTMA aliphatic esters. 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate (HATU)-catalyzed coupling of PTMA and 33 aminobenzoates resulted in the synthesis of 28 substituted aminobenzoate analogues of PTM, among which 26 of them were reported for the first time. Several of the PTM analogues showed weak antibacterial activity against methicillin-resistant Staphylococcus aureus. Our study supported the potential utility to integrate natural product biosynthetic and semi-synthetic approaches for structure diversification.Entities:
Keywords: Halogen-substituted aminobenzoate; Methicillin-resistant Staphylococcus aureus; Platensic acid; Platensimycin
Year: 2016 PMID: 28626267 PMCID: PMC5471356 DOI: 10.1016/j.tet.2016.12.059
Source DB: PubMed Journal: Tetrahedron ISSN: 0040-4020 Impact factor: 2.457